A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the ...

Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to sign off on ...

Johnson & Johnson has been fighting thousands of lawsuits over its now-discontinued talc products for 16 years. A pending ...

J&J said it is seeking a preliminary injunction for Samsung Bioepis' Stelara biosimilar over an unauthorized sublicense deal ...

Opponents of the J&J proposal argue the settlement should not bind those who do not like the terms and would prefer to take their chances in court. But J&J argues that bankruptcy offers a faster ...

By pushing the deal through a subsidiary’s bankruptcy, J&J is trying to force women with ovarian cancer to accept lower settlement payments based on a deeply flawed vote, according to opponents.

Under a settlement inked with J&J in late 2023, Samsung Bioepis and Sandoz got the all-clear to launch their Stelara biosimilar from Feb. 22, 2025. The settlement is one of many J&J has inked over ...

A top Kremlin aide said Thursday that any Ukraine peace settlement must secure Russia's "interests", and that President Vladimir Putin would probably give his opinion on a 30-day US ceasefire proposal ...